Dendrite Announces Proposed Public Equity Offering.MORRISTOWN, N.J.--(BUSINESS WIRE)--Jan. 27, 1999--Dendrite International, Inc. (NASDAQ/NMS:DRTE DRTE Defence Research Telecommunications Establishment ), today, announced its intent to file with the Securities and Exchange Commission a Registration Statement on Form S-3 expected to cover an aggregate of up to 3,250,000 shares of Common Stock. Such shares are expected to be offered to the public in an underwritten offering Underwritten offering A purchase and sale. . If the full 3,250,000 shares are offered to the public, 2,750,000 are expected to be offered by the Company and 500,000 are expected to be offered by certain stockholders of the Company. The selling stockholders are also expected to grant the underwriters an option to purchase an additional 450,000 shares under certain circumstances. Founded in 1986, Dendrite dendrite: see nervous system; synapse. International, Inc. completed an initial public offering in 1995 and is publicly traded on NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on under the symbol DRTE. Note: Dendrite is a registered trademark of Dendrite International, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion